Company: HCTI
Filing Date: 2025-11-19
Form Type: 424B5
Source: 0001213900-25-112544
Chunk: 11

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-19
Form: 424B5
Chunk 11
---
 2025, and October 8, 2025 (together the “Closing Date”). The Company received
aggregate gross proceeds of approximately $2.85 million in the Warrant Inducement, before deducting advisory fees and other expenses payable
by the Company. In consideration of the Holders’ immediate exercise of the PIPE Warrants in accordance with the Inducement Agreement,
we issued to the Holders warrants to purchase up to 1,429,528 shares of Common Stock at an exercise price of $3.00 per share (the “October
2025 Warrants”). We also issued warrants to purchase up to 28,590 shares of our common stock at an exercise price of $3.00 per share
(the “FA Warrants”) to the financial advisor to the Warrant Inducement.

Reverse Stock Split. On August 1,
2025, we effected a one-for-two hundred forty-nine (1:249) reverse stock split of all issued and outstanding shares of our common stock
effective as of 12:01 a.m. Eastern Time on August 1, 2025 (the “Reverse Stock Split”). As a result of the Reverse Stock Split,
every two hundred forty-nine (249) shares of issued and outstanding common stock combined into one (1) validly issued, fully paid and
nonassessable share of Common Stock. Proportional adjustments have also been made to the Company’s outstanding warrants, stock options,
and convertible securities, as well as to the reserves available pursuant to the terms of the Company’s 2020 Equity Incentive Plans
to reflect the Reverse Stock Split, in each case, in accordance with the terms thereof.

The Reverse Stock Split reduced the number of
shares of Common Stock issued and outstanding from 1,452,124,283 to 5,831,816 shares of Common Stock. The number of authorized shares
of Common Stock did not change by the Reverse Stock Split.

Asset Transfer Agreement. On
June 16, 2025, the Company and Niyama Healthcare, Inc., a Delaware corporation, a provider of Mental Health and Hospital Information Systems
technology, across India, South East Asia, and Europe (“Niyama”) entered into an Asset Transfer Agreement, which was amended
on June 23, 2025 (the “ATA”). Pursuant to the ATA, the Company agreed to purchase from Niyama, the Transferred Assets (as
defined below), and (ii) Niyama